litlas
Log inCreate account

Robert Schlegel

Active 1975–2019

67
Papers
27,013
Citations
65
h-index
67
i10-index

Citations

Citations per year for Robert Schlegel1948: 1 citations1976: 3 citations1979: 1 citations1980: 1 citations1981: 1 citations1982: 8 citations1983: 5 citations1984: 20 citations1985: 14 citations1986: 15 citations1987: 24 citations1988: 17 citations1989: 10 citations1990: 23 citations1991: 31 citations1992: 24 citations1993: 31 citations1994: 34 citations1995: 48 citations1996: 81 citations1997: 124 citations1998: 161 citations1999: 166 citations2000: 178 citations2001: 165 citations2002: 145 citations2003: 139 citations2004: 155 citations2005: 109 citations2006: 97 citations2007: 83 citations2008: 83 citations2009: 92 citations2010: 81 citations2011: 134 citations2012: 201 citations2013: 296 citations2014: 343 citations2015: 393 citations2016: 400 citations2017: 386 citations2018: 374 citations2019: 936 citations2020: 1,041 citations2021: 1,140 citations2022: 778 citations2023: 542 citations2024: 871 citations2025: 420 citations2026: 41 citations1949–1975: no citations, so these years are not shown1977–1978: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,891 citing papers, 33.6% of this breakdownChina: 1,605 citing papers, 11% of this breakdownUnited Kingdom: 886 citing papers, 6.1% of this breakdownGermany: 808 citing papers, 5.5% of this breakdownCanada: 484 citing papers, 3.3% of this breakdownFrance: 480 citing papers, 3.3% of this breakdownJapan: 474 citing papers, 3.3% of this breakdownItaly: 462 citing papers, 3.2% of this breakdownSwitzerland: 378 citing papers, 2.6% of this breakdownNetherlands: 361 citing papers, 2.5% of this breakdownSpain: 358 citing papers, 2.5% of this breakdownAustralia: 346 citing papers, 2.4% of this breakdown
0%33.6%Other 20.7%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology49.5%
  • Medicine33.5%
  • Computer Science6.8%
  • Immunology and Microbiology5.6%
  • Neuroscience0.9%
  • Chemistry0.8%
  • Other2.9%

Topics

  • Computational Drug Discovery Methods3.5%
  • Cancer Genomics and Diagnostics3%
  • Bioinformatics and Genomic Networks2.9%
  • RNA modifications and cancer2.1%
  • Melanoma and MAPK Pathways2.1%
  • Cancer-related Molecular Pathways2%
  • Other84.4%

Coauthors

All papers

Open in search
  1. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

    Authors: Jordi Barretina, Giordano Caponigro, Nicolas Stransky, K. Venkatesan, Adam A. Margolin, Sung Joon Kim, Christopher J. Wilson, Joseph Lehár, Gregory V. Kryukov, Dmitriy Sonkin, Anupama Reddy, Manway Liu, Lauren Murray, Michael F. Berger, John E. Monahan, Paula Morais, Jodi Meltzer, Adam Korejwa, Judit Jané‐Valbuena, Felipa Mapa, Joseph Thibault, Eva Bric-Furlong, Pichai Raman, Aaron Shipway, Ingo H. Engels, Jill Cheng, Guoying Karen Yu, Jianjun Yu, Peter Aspesi, Melanie de Silva, Kalpana Jagtap, Michael D. Jones, Li Wang, Charlie Hatton, Emanuele Palescandolo, Supriya Gupta, Scott Mahan, Carrie Sougnez, Robert C. Onofrio, Ted Liefeld, Laura E. MacConaill, Wendy Winckler, Michael Reich, Nanxin Li, Jill P. Mesirov, Stacey Gabriel, Gad Getz, Kristin Ardlie, Vivien W. Chan, Vic E. Myer, Barbara L. Weber, Jeff Porter, Markus Warmuth, Peter M. Finan, Jennifer L. Harris, Matthew Meyerson, Todd R. Golub, Michael Morrissey, William R. Sellers, Robert Schlegel, Levi A. Garraway - Nature 2012 cited by 8,599

  2. Next-generation characterization of the Cancer Cell Line Encyclopedia

    Authors: Mahmoud Ghandi, Franklin W. Huang, Judit Jané‐Valbuena, Gregory V. Kryukov, Christopher Lo, E. Robert McDonald, Jordi Barretina, Ellen Gelfand, Craig M. Bielski, Haoxin Li, Kevin Hu, Alexander Andreev-Drakhlin, Jaegil Kim, Julian M. Hess, Brian J. Haas, François Aguet, Barbara A. Weir, Michael Rothberg, Brenton R. Paolella, Michael S. Lawrence, Rehan Akbani, Yiling Lu, Hong L. Tiv, Prafulla C. Gokhale, Antoine de Weck, Ali Amin Mansour, Coyin Oh, Juliann Shih, Kevin Hadi, Yanay Rosen, Jonathan Bistline, K. Venkatesan, Anupama Reddy, Dmitriy Sonkin, Manway Liu, Joseph Lehár, Joshua M. Korn, Dale Porter, Michael D. Jones, Javad Golji, Giordano Caponigro, Jordan E. Taylor, Caitlin M. Dunning, Amanda L. Creech, Allison Warren, James M. McFarland, Mahdi Zamanighomi, Audrey Kauffmann, Nicolas Stransky, Marcin Imieliński, Yosef E. Maruvka, Andrew D. Cherniack, Aviad Tsherniak, Francisca Vázquez, Jacob D. Jaffe, Andrew A. Lane, David M. Weinstock, Cory M. Johannessen, Michael Morrissey, Frank Stegmeier, Robert Schlegel, William C. Hahn, Gad Getz, Gordon B. Mills, Jesse S. Boehm, Todd R. Golub, Levi A. Garraway, William R. Sellers - Nature 2019 cited by 3,761

  3. Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors

    Authors: Garrett M. Frampton, Siraj M. Ali, Mark R. Rosenzweig, Juliann Chmielecki, Xinyuan Lu, Todd M. Bauer, Mikhail Akimov, José A. Bufill, Carrie B. Lee, David Jentz, Rick Hoover, Sai‐Hong Ignatius Ou, Ravi Salgia, Timothy J. Brennan, Zachary R. Chalmers, Savina Jaeger, Alan Huang, Julia A. Elvin, Rachel Erlich, Alex Fichtenholtz, Kyle Gowen, Joel Greenbowe, Adrienne Johnson, Depinder Khaira, Caitlin McMahon, Eric M. Sanford, Steven Roels, Jared White, Joel Greshock, Robert Schlegel, Doron Lipson, Roman Yelensky, Deborah Morosini, Jeffrey S. Ross, Eric A. Collisson, Malte Peters, Philip J. Stephens, Vincent A. Miller - Cancer Discovery 2015 cited by 796

  4. Characterization of the Novel and Specific PI3Kα Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials

    Authors: Christine Fritsch, Alan Huang, Christian Chatenay‐Rivauday, Christian Schnell, Anupama Reddy, Manway Liu, Audrey Kauffmann, Daniel Guthy, Dirk Erdmann, Alain De Pover, Pascal Furet, Hui Gao, Stéphane Ferretti, Youzhen Wang, Joerg Trappe, Saskia M. Brachmann, Sauveur-Michel Maira, Christopher J. Wilson, Markus Boehm, Carlos Garcı́a-Echeverrı́a, Patrick Chêne, Marion Wiesmann, Robert Cozens, Joseph Lehár, Robert Schlegel, Giorgio Caravatti, Francesco Hofmann, William R. Sellers - Molecular Cancer Therapeutics 2014 cited by 496

  5. CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors

    Authors: Sadhna Vora, Dejan Juric, Nayoon Kim, Mari Mino–Kenudson, Tiffany G. Huynh, Carlotta Costa, Elizabeth L. Lockerman, Sarah F. Pollack, Manway Liu, Xiaoyan Li, Joseph Lehár, Marion Wiesmann, Markus Wartmann, Yan Chen, Z. Alexander Cao, Maria Pinzon-Ortiz, Sunkyu Kim, Robert Schlegel, Alan Huang, Jeffrey A. Engelman - Cancer Cell 2014 cited by 439

  6. COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

    Authors: Cory M. Johannessen, Jesse S. Boehm, So Young Kim, Sapana Thomas, Leslie Wardwell, Laura A. Johnson, Caroline M. Emery, Nicolas Stransky, Alexandria P. Cogdill, Jordi Barretina, Giordano Caponigro, Haley Hieronymus, Ryan R. Murray, Kourosh Salehi‐Ashtiani, David E. Hill, Marc Vidal, Jean J. Zhao, Xiaoping Yang, Ozan Alkan, Sung Joon Kim, Jennifer L. Harris, Christopher J. Wilson, Vic E. Myer, Peter M. Finan, David E. Root, Thomas M. Roberts, Todd R. Golub, Keith T. Flaherty, Reinhard Dummer, Barbara L. Weber, William R. Sellers, Robert Schlegel, Jennifer A. Wargo, William C. Hahn, Levi A. Garraway - Nature 2010 cited by 1,465

  7. Pharmacogenomic agreement between two cancer cell line data sets

    Authors: Nicolas Stransky, Mahmoud Ghandi, Gregory V. Kryukov, Levi A. Garraway, Arnaud Amzallag, Iulian Pruteanu-Malinici, Daniel A. Haber, Sridhar Ramaswamy, Cyril H. Benes, Joseph Lehár, Manway Liu, Dmitriy Sonkin, Audrey Kauffmann, Kavitha Venkatesan, Elena J. Edelman, Markus Riester, Jordi Barretina, Giordano Caponigro, Robert Schlegel, William R. Sellers, Frank Stegmeier, Michael Morrissey, Michael P. Menden, Francesco Iorio, Julio Saez-Rodriguez, Michael R. Stratton, Ultan McDermott, Mathew J. Garnett - Nature 2015 cited by 444

  8. Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor

    Authors: Sauveur-Michel Maira, Sabina Pecchi, Alan Huang, Matthew T. Burger, Mark Knapp, Dario Sterker, Christian Schnell, Daniel Guthy, Tobi Nagel, Marion Wiesmann, Saskia M. Brachmann, Christine Fritsch, Marion Dorsch, Patrick Chêne, Kevin Shoemaker, Alain De Pover, Daniel L. Menezes, Georg Martiny‐Baron, Doriano Fabbro, Christopher J. Wilson, Robert Schlegel, Francesco Hofmann, Carlos Garcı́a-Echeverrı́a, William R. Sellers, Charles F. Voliva - Molecular Cancer Therapeutics 2011 cited by 529

  9. Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia

    Authors: Jacob D. Jaffe, Yan Wang, Ho Man Chan, Jinghui Zhang, Robert Huether, Gregory V. Kryukov, Hyo-Eun Carrie Bhang, Jordan E. Taylor, Min Hu, Nathan Englund, Feng Yan, Zhaofu Wang, E. Robert McDonald, Lei Wei, Jing Ma, John Easton, Zhengtian Yu, Rosalie deBeaumount, Veronica Gibaja, K. Venkatesan, Robert Schlegel, William R. Sellers, Nicholas Keen, Jun Liu, Giordano Caponigro, Jordi Barretina, Vesselina G. Cooke, Charles G. Mullighan, Steven A. Carr, James R. Downing, Levi A. Garraway, Frank Stegmeier - Nature Genetics 2013 cited by 284

  10. Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway–dependent and PI3K pathway–independent mechanisms

    Authors: Pixu Liu, Hailing Cheng, Stephanie Santiago, Maria B. Ræder, Fan Zhang, Adam J. Isabella, Janet Z. Yang, Derek J Semaan, Changzhong Chen, Edward A. Fox, Nathanael S. Gray, John E. Monahan, Robert Schlegel, Rameen Beroukhim, Gordon B. Mills, Jean J. Zhao - Nature Medicine 2011 cited by 261

  11. Phosphatidylserine, a death knell

    Authors: Robert Schlegel, Paula Williamson - Cell Death and Differentiation 2001 cited by 359

  12. The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation

    Authors: David P. Kodack, Vasileios Askoxylakis, Gino B. Ferraro, Qing Sheng, Mark Badeaux, Shom Goel, Xiaolong Qi, Ram C. Shankaraiah, Zheng Cao, Rakesh R. Ramjiawan, Divya Bezwada, Bhushankumar Patel, Yongchul Song, Carlotta Costa, Kamila Naxerova, Christina S.F. Wong, Jonas Kloepper, Rita Das, Angela Tam, Jantima Tanboon, Dan G. Duda, C. Ryan Miller, Marni B. Siegel, Carey K. Anders, Melinda E. Sanders, Mónica V. Estrada, Robert Schlegel, Carlos L. Arteaga, Elena F. Brachtel, Alan Huang, Dai Fukumura, Jeffrey A. Engelman, Rakesh K. Jain - Science Translational Medicine 2017 cited by 111

  13. Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages

    Authors: Stephen Krahling, Melissa K. Callahan, Patrick Williamson, Robert Schlegel - Cell Death and Differentiation 1999 cited by 210

  14. Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

    Authors: Jordi Barretina, Giordano Caponigro, Nicolas Stransky, K. Venkatesan, Adam A. Margolin, Sung Joon Kim, Christopher J. Wilson, Joseph Lehár, Gregory V. Kryukov, Dmitriy Sonkin, Anupama Reddy, Manway Liu, Lauren Murray, Michael F. Berger, John E. Monahan, Paula Morais, Jodi Meltzer, Adam Korejwa, Judit Jané‐Valbuena, Felipa Mapa, Joseph Thibault, Eva Bric-Furlong, Pichai Raman, Aaron Shipway, Ingo H. Engels, Jill Cheng, Guoying Karen Yu, Jianjun Yu, Peter Aspesi, Melanie de Silva, Kalpana Jagtap, Michael D. Jones, Li Wang, Charlie Hatton, Emanuele Palescandolo, Supriya Gupta, Scott Mahan, Carrie Sougnez, Robert C. Onofrio, Ted Liefeld, Laura E. MacConaill, Wendy Winckler, Michael Reich, Nanxin Li, Jill P. Mesirov, Stacey Gabriel, Gad Getz, Kristin Ardlie, Vivien W. Chan, Vic E. Myer, Barbara L. Weber, Jeff Porter, Markus Warmuth, Peter M. Finan, Jennifer L. Harris, Matthew Meyerson, Todd R. Golub, Michael Morrissey, William R. Sellers, Robert Schlegel, Levi A. Garraway - Nature 2012 cited by 112

  15. FGFR-Mediated Reactivation of MAPK Signaling Attenuates Antitumor Effects of Imatinib in Gastrointestinal Stromal Tumors

    Authors: Fang Li, Hung Huynh, Xiaoyan Li, David A. Ruddy, Youzhen Wang, Richard Ong, Pierce K. H. Chow, Shumei Qiu, Angela Tam, Daniel P. Rakiec, Robert Schlegel, John E. Monahan, Alan Huang - Cancer Discovery 2015 cited by 107

  16. Phosphatidylserine on HIV Envelope Is a Cofactor for Infection of Monocytic Cells

    Authors: Melissa K. Callahan, Paul M. Popernack, Shigeki Tsutsui, Linh Truong, Robert Schlegel, Andrew J. Henderson - The Journal of Immunology 2003 cited by 139

  17. Ventriculoatrial Shunt Infection Due to Cryptococcus neoformans: An Ultrastructural and Quantitative Microbiological Study

    Authors: Thomas J. Walsh, Robert Schlegel, Marcia M. Moody, J. W. Costerton, Michael Salcman - Neurosurgery 1986 cited by 98

  18. A Subfamily of P-Type ATPases with Aminophospholipid Transporting Activity

    Authors: Xiaojing Tang, Margaret S. Halleck, Robert Schlegel, Patrick Williamson - Science 1996 cited by 475

  19. Maintenance of adenomatous polyposis coli ( APC )-mutant colorectal cancer is dependent on Wnt/β-catenin signaling

    Authors: Alix Scholer‐Dahirel, Michael R. Schlabach, Alice Loo, Linda Bagdasarian, Ronald A. Meyer, Ribo Guo, Steve Woolfenden, Kristine Yu, Judit Markovits, Karen A. Killary, Dmitry Sonkin, Yung‐Mae Yao, Markus Warmuth, William R. Sellers, Robert Schlegel, Frank Stegmeier, Rebecca Mosher, Margaret E. McLaughlin - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 cited by 116

  20. Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease

    Authors: Maxwell P. Westerman, David Green, Alice Gilman‐Sachs, Kenneth Beaman, Sally Freels, Lisa Boggio, Sandra Allen, L Zuckerman, Robert Schlegel, Patrick Williamson - Journal of Laboratory and Clinical Medicine 1999 cited by 141

  21. Lipid Specific Activation of the Murine P4-ATPase Atp8a1 (ATPase II)

    Authors: Jill K. Paterson, Kathleen Renkema, Lisa M. Burden, Margaret S. Halleck, Robert Schlegel, Patrick Williamson, David L. Daleke - Biochemistry 2006 cited by 77

  22. Comparison of protein A affinity sorbents

    Authors: Rainer Hahn, Robert Schlegel, Alois Jungbauer - Journal of Chromatography B 2003 cited by 243

  23. Merocyanine 540, a fluorescent probe sensitive to lipid packing

    Authors: Patrick Williamson, Karen Mattocks, Robert Schlegel - Biochimica et Biophysica Acta (BBA) - Biomembranes 1983 cited by 234

  24. A Smac Mimetic Rescue Screen Reveals Roles for Inhibitor of Apoptosis Proteins in Tumor Necrosis Factor-α Signaling

    Authors: Alex Gaither, Dale Porter, Yao Yao, Jason Borawski, Guang Yang, Jerry Donovan, David R. Sage, Joanna Slisz, Mary Tran, Christopher Straub, Tim Ramsey, Vadim Iourgenko, Alan Huang, Yan Chen, Robert Schlegel, Mark Labow, Stephen E. Fawell, William R. Sellers, Leigh Zawel - Cancer Research 2007 cited by 225